344 related articles for article (PubMed ID: 35433958)
1. Integrative bioinformatics analysis of potential therapeutic targets and immune infiltration characteristics in dilated cardiomyopathy.
Yang Y; Liu P; Teng R; Liu F; Zhang C; Lu X; Ding Y
Ann Transl Med; 2022 Mar; 10(6):348. PubMed ID: 35433958
[TBL] [Abstract][Full Text] [Related]
2. Bioinformatics prediction of potential mechanisms and biomarkers underlying dilated cardiomyopathy.
Liu Z; Song YN; Chen KY; Gao WL; Chen HJ; Liang GY
World J Cardiol; 2022 May; 14(5):282-296. PubMed ID: 35702326
[TBL] [Abstract][Full Text] [Related]
3. Screening and identification of potential hub genes and immune cell infiltration in the synovial tissue of rheumatoid arthritis by bioinformatic approach.
Feng ZW; Tang YC; Sheng XY; Wang SH; Wang YB; Liu ZC; Liu JM; Geng B; Xia YY
Heliyon; 2023 Jan; 9(1):e12799. PubMed ID: 36699262
[TBL] [Abstract][Full Text] [Related]
4. Identification and Verification of Feature Biomarkers Associated With Immune Cells in Dilated Cardiomyopathy by Bioinformatics Analysis.
Zhu T; Wang M; Quan J; Du Z; Li Q; Xie Y; Lin M; Xu C; Xie Y
Front Genet; 2022; 13():874544. PubMed ID: 35646094
[No Abstract] [Full Text] [Related]
5. Exploring the pathogenesis and immune infiltration in dilated cardiomyopathy complicated with atrial fibrillation by bioinformatics analysis.
Gan T; Hu J; Aledan AKO; Liu W; Li C; Lu S; Wang Y; Xu Q; Wang Y; Wang Z
Front Immunol; 2023; 14():1049351. PubMed ID: 36733486
[TBL] [Abstract][Full Text] [Related]
6. Integrated microarray analysis to identify potential biomarkers and therapeutic targets in dilated cardiomyopathy.
Zhang H; Huo J; Jiang W; Shan Q
Mol Med Rep; 2020 Aug; 22(2):915-925. PubMed ID: 32626989
[TBL] [Abstract][Full Text] [Related]
7. Exploring the Communal Pathogenesis, Ferroptosis Mechanism, and Potential Therapeutic Targets of Dilated Cardiomyopathy and Hypertrophic Cardiomyopathy
Wang Z; Xia Q; Su W; Cao M; Sun Y; Zhang M; Chen W; Jiang T
Front Cardiovasc Med; 2022; 9():824756. PubMed ID: 35282347
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive analysis of miRNA-mRNA regulatory network and potential drugs in chronic chagasic cardiomyopathy across human and mouse.
Wu J; Cao J; Fan Y; Li C; Hu X
BMC Med Genomics; 2021 Nov; 14(1):283. PubMed ID: 34844599
[TBL] [Abstract][Full Text] [Related]
9. Novel diagnostic biomarkers related to immune infiltration in Parkinson's disease by bioinformatics analysis.
Zhang P; Zhao L; Li H; Shen J; Li H; Xing Y
Front Neurosci; 2023; 17():1083928. PubMed ID: 36777638
[TBL] [Abstract][Full Text] [Related]
10. Identification of the Key Genes of Immune Infiltration in Dilated Cardiomyopathy.
Qi B; Wang HY; Ma X; Chi YF; Gui C
Int Heart J; 2023 Nov; 64(6):1054-1064. PubMed ID: 37967988
[TBL] [Abstract][Full Text] [Related]
11. Integrated Bioinformatics Algorithms and Experimental Validation to Explore Robust Biomarkers and Landscape of Immune Cell Infiltration in Dilated Cardiomyopathy.
Zhang Q; Fan M; Cao X; Geng H; Su Y; Wu C; Pan H; Pan M
Front Cardiovasc Med; 2022; 9():809470. PubMed ID: 35433865
[TBL] [Abstract][Full Text] [Related]
12. Exploration of dilated cardiomyopathy for biomarkers and immune microenvironment: evidence from RNA-seq.
Fang C; Lv Z; Yu Z; Wang K; Xu C; Li Y; Wang Y
BMC Cardiovasc Disord; 2022 Jul; 22(1):320. PubMed ID: 35850644
[TBL] [Abstract][Full Text] [Related]
13. Identification of Immune Markers in Dilated Cardiomyopathies with Heart Failure by Integrated Weighted Gene Coexpression Network Analysis.
Wang X; Guan H; Liu W; Li H; Ding J; Feng Y; Chen Z
Genes (Basel); 2022 Feb; 13(3):. PubMed ID: 35327947
[TBL] [Abstract][Full Text] [Related]
14. Role of mitochondrial metabolic disorder and immune infiltration in diabetic cardiomyopathy: new insights from bioinformatics analysis.
Peng C; Zhang Y; Lang X; Zhang Y
J Transl Med; 2023 Feb; 21(1):66. PubMed ID: 36726122
[TBL] [Abstract][Full Text] [Related]
15. Identification and Validation of Dilated Cardiomyopathy-Related Genes via Bioinformatics Analysis.
Wang LJ; Qiu BQ; Yuan MM; Zou HX; Gong CW; Huang H; Lai SQ; Liu JC
Int J Gen Med; 2022; 15():3663-3676. PubMed ID: 35411175
[TBL] [Abstract][Full Text] [Related]
16. Construction of Immune-Related ceRNA Network in Dilated Cardiomyopathy: Based on Sex Differences.
Liu C; Liu J; Wu D; Luo S; Li W; Chen L; Liu Z; Yu B
Front Genet; 2022; 13():882324. PubMed ID: 35754849
[No Abstract] [Full Text] [Related]
17. Identification of cuproptosis-related genes and immune infiltration in dilated cardiomyopathy.
Lin Y; Chen K; Guo J; Chen P; Qian ZR; Zhang T
Int J Cardiol; 2024 Mar; 399():131702. PubMed ID: 38168558
[TBL] [Abstract][Full Text] [Related]
18. Development and validation of risk prediction and neural network models for dilated cardiomyopathy based on WGCNA.
Yu W; Li L; Tan X; Liu X; Yin C; Cao J
Front Med (Lausanne); 2023; 10():1239056. PubMed ID: 37869159
[TBL] [Abstract][Full Text] [Related]
19. Identification of key immune-related genes in dilated cardiomyopathy using bioinformatics analysis.
Li F; Du TY; Wu LD; Zhang L; Liu HH; Zhang ZY; Zhang J; Zhang ZY; Qian LL; Wang RX; Hao JF
Sci Rep; 2023 Feb; 13(1):1820. PubMed ID: 36725968
[TBL] [Abstract][Full Text] [Related]
20. Identification of the Immune Status of Hypertrophic Cardiomyopathy by Integrated Analysis of Bulk- and Single-Cell RNA Sequencing Data.
Zhao W; Wu T; Zhan J; Dong Z
Comput Math Methods Med; 2022; 2022():7153491. PubMed ID: 36238494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
